ReCode Therapeutics is a biopharmaceutical company developing precision medicines for genetic
respiratory diseases with significant unmet medical need. ReCode’s diverse pipeline includes lead
programs for primary ciliary dyskinesia and nonsense mutations in cystic fibrosis. The Company’s
proprietary non-viral lipid nanoparticle platform enables the delivery of a variety of payloads, and
precise organ targeting of nucle...
ReCode Therapeutics is a biopharmaceutical company developing precision medicines for genetic
respiratory diseases with significant unmet medical need. ReCode’s diverse pipeline includes lead
programs for primary ciliary dyskinesia and nonsense mutations in cystic fibrosis. The Company’s
proprietary non-viral lipid nanoparticle platform enables the delivery of a variety of payloads, and
precise organ targeting of nucleic acid and protein payloads via both systemic and local delivery.
ReCode is leveraging its nanoparticle and nucleic acid technologies across multiple modalities.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.